Author:
Avila Meera B.,Avila Nathaniel P.,Dupont Andrew W.
Abstract
Clostridium difficileinfection (CDI) has become the most frequently reported health care-associated infection in the United States [1]. As the incidence of CDI rises, so too does the burden it produces on health care and society. In an attempt to decrease the burden of CDI and provide the best outcomes for patients affected by CDI, there have been many recent advancements in the understanding, diagnosis, and management of CDI. In this article, we review the current recommendations regarding CDI testing and treatment strategies.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference50 articles.
1. Multistate point-prevalence survey of health care-associated infections.;S Magill;N Engl J Med.,2014
2. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.;L Kyne;N Engl J Med.,2000
3. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.;A Lo Vecchio;Curr Opin Gastroenterol.,2012
4. Vital signs: preventing Clostridium difficile infections.;MMWR Morb Mortal Wkly Rep.,2012
5. Clostridium difficile Infections (CDI) in Hospital Stays, 2009. HCUP Statistical Brief #124;J Lucado,2012
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献